Addus HomeCare Corporation (Nasdaq: ADUS) is anticipating slow-churning growth across its trifecta of home-based services. The company projected evolving hospice industry dynamics over the next year. Texas-headquartered Addus provides personal care, home health and hospice services in 23 states. The company anticipates scalable expansion of its hospice segment to be driven by a mix of […]
Addus HomeCare Corporation’s (Nasdaq: ADUS) purchase of Gentiva’s personal care segment is bearing fruit as the company drives forward on its acquisition strategy in 2025. But labor constraints and evolving reimbursement pressures could complicate the growth of its hospice and home-based services. The Texas-headquartered personal care, home health and hospice provider is narrowing its strategic […]
Hospice News explores the issues garnering growing attention in end-of-life care delivery in seven of this year’s “hidden gem” stories. Topics span trends related to program integrity, workforce development, health equity, service diversification and the keys to hospices’ growth strategies. Hospice Investors to Watch Hospice merger and acquisition (M&A) activity has seen a cooling period […]
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority. But this […]
Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. Like many hospice providers, Addus has faced COVID-19 challenges that include reduced patient volumes and shorter length of […]
In 2022, the hospice community laid the groundwork for a transformational 2023. This year saw industry-changing acquisitions, some of the worst labor headwinds to date, the return of sequestration and a sometimes volatile national economy. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice […]
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]
Labor shortages and other headwinds have battered hospices during 2022, including large companies. Some of these providers are making near-term investments that cut into revenue but are expected to pay off in the long run. Providers are seeing troubles on multiple fronts, as reflected in third quarter earnings reports. This year brought the return of […]
Hospices are beginning to leverage technologies used to identify eligible patients in need to recruit and retain staff amid ongoing workforce shortages. Systems like artificial intelligence (AI), predictive analytics, and machine learning have helped providers identify eligible patients sooner in their disease process. Hospices are now applying those tools to help relieve industry-wide labor pressures. […]
The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice. The U.S. Centers for Medicare & Medicaid Services (CMS) […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
